Tuesday, Nov 12 2019 | Time 11:13 Hrs(IST)
image
  • Gurpurab celebrated with religious fervour in Jammu
  • IPFT to hold demonstration in Delhi on Nov 28 for Tipraland
  • President accepts Sawant's resignation, Javadekar given additional charge
  • Two militants killed in Ganderbal encounter
  • Death toll from Cyclone Bulbul in Bangladesh rises to 26 - Reports
  • At least 15 killed in Bangladesh train collision
  • US calls on Hong Kong protesters, police to exercise restraint, condemns violence
  • Bolivia’s Evo Morales says leaving for Mexico, but will return ‘With More Strength’
  • Mexican plane headed to pick up Morales refuels in Peru – Peru’s Foreign Ministry
  • Over 30 Bolivian regional election commission members arrested - Reports
  • Macron holds phone talks with Trump, leaders agree to meet before December 3-4 NATO Summit
  • Trump says will release transcript of first phone call with Ukraine’s president this week
  • US House Democrats release transcripts of Anderson, Croft impeachment testimonies
  • Google collects US citizens' health data as part of secret project - Reports
  • Trump to put off final decision on import duties on EU cars, auto parts - Reports
Science Technology


Russia gives alpha emitter for India's 2nd lunar mission

Russia gives alpha emitter for India's 2nd lunar mission

New Delhi, Feb 14 (UNI) Russian state-run Rosatom is supplying pure alpha emitter for India’s second lunar mission Chandrayan-2 to help it analyse the moon’s surface. The alpha emitter, Radionuclide curium-244 (Cm-244) manufactured by Russian “State Scientific Center - Research Institute of Atomic Reactors” (JSC SSC RIAR) enables sources to determine chemical composition of any rocks and soils. It will be installed on the Alpha Proton X-Ray Spectrometer (APXS) aimed at analysing the lunar surface, a company spokesperson said today .The launch of second Chndrayan spacecraft is scheduled for 2018. Cm-244 production is produced by only two countries in the world- Russia and the US. UNI NAZ SW SNU 1518

More News
Max number of breast cancer patients in India are in 40-60 age group: Expert

Max number of breast cancer patients in India are in 40-60 age group: Expert

31 Oct 2019 | 4:01 PM

New Delhi, Oct 31 (UNI) The maximum number of patients diagnosed with breast cancer in India are in the age group of 40-60 years, says a health expert.

see more..
Guidelines for evaluation of Nanopharmaceuticals in India released

Guidelines for evaluation of Nanopharmaceuticals in India released

24 Oct 2019 | 9:37 PM

New Delhi, Oct 24 (UNI) Union Minister for Science and Technology Dr Harsh Vardhan on Thursday said that “Guidelines for Evaluation of Nanopharmaceuticals in India” is one of the most important steps for delineating quality, safety and efficacy assessment of the novel nano-formulations.

see more..
Scientists discover how to detect precancerous conditions with nanodiamonds

Scientists discover how to detect precancerous conditions with nanodiamonds

10 Oct 2019 | 12:30 PM

New Delhi, Oct 10 (UNI) Scientists have been actively exploring Detonation nanodiamonds' (DNDs) interaction with biological structures and biomacromolecules and now, the findings are being used to treat tumours, as well as to develop biosensors and biocompatible implants.

see more..
SGRH completes 1000 Vascular Surgery cases in Artis Q Hybrid OR

SGRH completes 1000 Vascular Surgery cases in Artis Q Hybrid OR

04 Oct 2019 | 9:37 PM

New Delhi, Oct 4 (UNI) The Institute of vascular and endovascular sciences at Sir Ganga Ram Hospital (SGRH) has successfully completed 1000 cases of vascular surgery in Artis Q Hybrid OR.

see more..
Charting the 'Generic' terrain for future

Charting the 'Generic' terrain for future

26 Sep 2019 | 3:19 PM

By Rishira Jain
New Delhi, Sep 26 (UNI) For India to grow, healthcare, as the engine of the economy, needs to flourish and to make the affordable medication a reality, generic drugs is the only charted terrain in the country that can ensure affordable access to healthcare and the future sustainability of medicines development.

see more..
image